Stonehage Fleming Financial Services Holdings LTD Immunity Bio, Inc. Transaction History

Stonehage Fleming Financial Services Holdings LTD

  • $3.78 Billion
  • Q3 2024

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 01, 2023
BUY
$1.29 - $3.1 $109,650 - $263,500
85,000 New
85,000 $143,000
Q1 2022

May 11, 2022
BUY
$5.05 - $7.53 $303,000 - $451,800
60,000 New
60,000 $336,000

Others Institutions Holding IBRX

# of Institutions
202
Shares Held
70M
Call Options Held
1.68M
Put Options Held
1.31M
View Full List

About ImmunityBio, Inc.

IBRX Quotes by TradingView
  • Ticker IBRX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 400,304,000
  • Market Cap $1.8B
  • Description
  • ImmunityBio, Inc., a clinical-stage biotechnology company, develops therapies and vaccines to treat cancers and infectious diseases. It offers immunotherapy and cell therapy platforms, including antibody cytokine fusion proteins, synthetic immunomodulators, vaccine technologies, natural killer cells, and adaptive (T cell) immune systems. The com...
More about IBRX
Track This Portfolio

Track Stonehage Fleming Financial Services Holdings LTD Portfolio

Follow Stonehage Fleming Financial Services Holdings LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Stonehage Fleming Financial Services Holdings LTD, based on Form 13F filings with the SEC.

News

Stay updated on Stonehage Fleming Financial Services Holdings LTD with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email